<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: The genomic frontier: Personalized medicine in action</title>
	<atom:link href="http://venturebeat.com/2008/11/18/the-genomic-frontier-personalized-medicine-in-action/feed/" rel="self" type="application/rss+xml" />
	<link>http://venturebeat.com/2008/11/18/the-genomic-frontier-personalized-medicine-in-action/</link>
	<description>News About Tech, Money and Innovation</description>
	<lastBuildDate>Mon, 23 Nov 2009 13:10:15 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: David Lester</title>
		<link>http://venturebeat.com/2008/11/18/the-genomic-frontier-personalized-medicine-in-action/comment-page-1/#comment-861791</link>
		<dc:creator>David Lester</dc:creator>
		<pubDate>Wed, 26 Nov 2008 08:46:27 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/?p=100610#comment-861791</guid>
		<description>We hear these overviews of the powerful technologies associated with genomics and Personalized Medicine and the lofty expectations regarding their impact on the practice of medicine. The reality is that medicine will remain to some degree an art. So, much of it is trial and error and it is managed by payers and providers. Most of the drugs that are highly effective in the management of disease are really not understood in terms of how they actually work. The other reality is that new technologies take extensive periods of time to be adopted and integrated into clinical practice. The more complicated the technology, the more difficult it is to gain acceptance. The most significant reality is that we haven&#039;t figured out how to optimize medical technologies that exist on the market. These new technologies will take time before their impact on clinical practice is fully realized.</description>
		<content:encoded><![CDATA[<p>We hear these overviews of the powerful technologies associated with genomics and Personalized Medicine and the lofty expectations regarding their impact on the practice of medicine. The reality is that medicine will remain to some degree an art. So, much of it is trial and error and it is managed by payers and providers. Most of the drugs that are highly effective in the management of disease are really not understood in terms of how they actually work. The other reality is that new technologies take extensive periods of time to be adopted and integrated into clinical practice. The more complicated the technology, the more difficult it is to gain acceptance. The most significant reality is that we haven&#39;t figured out how to optimize medical technologies that exist on the market. These new technologies will take time before their impact on clinical practice is fully realized.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Genomics &#187; Empire Genomics signs 2 deals - Birmingham Business Journal</title>
		<link>http://venturebeat.com/2008/11/18/the-genomic-frontier-personalized-medicine-in-action/comment-page-1/#comment-834796</link>
		<dc:creator>Genomics &#187; Empire Genomics signs 2 deals - Birmingham Business Journal</dc:creator>
		<pubDate>Tue, 25 Nov 2008 07:17:04 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/?p=100610#comment-834796</guid>
		<description>[...] The genomic frontier: Personalized medicine in action - Venturebeat.com[Editor&#8217;s note: As we&#8217;ve reported , the economic downturn and frozen IPO market have been especially tough on health care companies. But that doesn&#8217;t mean innovation has slowed across the board. Below, Clifford Reid, chief executive of genome &#8230; [...]</description>
		<content:encoded><![CDATA[<p>[...] The genomic frontier: Personalized medicine in action &#8211; Venturebeat.com[Editor&#8217;s note: As we&#8217;ve reported , the economic downturn and frozen IPO market have been especially tough on health care companies. But that doesn&#8217;t mean innovation has slowed across the board. Below, Clifford Reid, chief executive of genome &#8230; [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Genomics &#187; The genomic frontier: Personalized medicine in action - Venturebeat.com</title>
		<link>http://venturebeat.com/2008/11/18/the-genomic-frontier-personalized-medicine-in-action/comment-page-1/#comment-834618</link>
		<dc:creator>Genomics &#187; The genomic frontier: Personalized medicine in action - Venturebeat.com</dc:creator>
		<pubDate>Sat, 22 Nov 2008 07:36:43 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/?p=100610#comment-834618</guid>
		<description>[...] The genomic frontier: Personalized medicine in action - Venturebeat.com[Editor&#8217;s note: As we&#8217;ve reported , the economic downturn and frozen IPO market have been especially tough on health care companies. But that doesn&#8217;t mean innovation has slowed across the board. Below, Clifford Reid, chief executive of genome &#8230; [...]</description>
		<content:encoded><![CDATA[<p>[...] The genomic frontier: Personalized medicine in action &#8211; Venturebeat.com[Editor&#8217;s note: As we&#8217;ve reported , the economic downturn and frozen IPO market have been especially tough on health care companies. But that doesn&#8217;t mean innovation has slowed across the board. Below, Clifford Reid, chief executive of genome &#8230; [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Genomics &#187; Woolly mammoth task: Extinct critter's DNA mapped - Forbes</title>
		<link>http://venturebeat.com/2008/11/18/the-genomic-frontier-personalized-medicine-in-action/comment-page-1/#comment-834398</link>
		<dc:creator>Genomics &#187; Woolly mammoth task: Extinct critter's DNA mapped - Forbes</dc:creator>
		<pubDate>Thu, 20 Nov 2008 07:18:01 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/?p=100610#comment-834398</guid>
		<description>[...] The genomic frontier: Personalized medicine in action - Venturebeat.com[Editor&#8217;s note: As we&#8217;ve reported , the economic downturn and frozen IPO market have been especially tough on health care companies. But that doesn&#8217;t mean innovation has slowed across the board. Below, Clifford Reid, chief executive of genome &#8230; [...]</description>
		<content:encoded><![CDATA[<p>[...] The genomic frontier: Personalized medicine in action &#8211; Venturebeat.com[Editor&#8217;s note: As we&#8217;ve reported , the economic downturn and frozen IPO market have been especially tough on health care companies. But that doesn&#8217;t mean innovation has slowed across the board. Below, Clifford Reid, chief executive of genome &#8230; [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: And now a word from the CEO of Complete Genomics - The Medical Quack .... by Barbara Duck - emrupdate.com</title>
		<link>http://venturebeat.com/2008/11/18/the-genomic-frontier-personalized-medicine-in-action/comment-page-1/#comment-834270</link>
		<dc:creator>And now a word from the CEO of Complete Genomics - The Medical Quack .... by Barbara Duck - emrupdate.com</dc:creator>
		<pubDate>Wed, 19 Nov 2008 03:45:53 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/?p=100610#comment-834270</guid>
		<description>[...] http://venturebeat.com/2008/11/18/the-genomic-frontier-personalized-medicine-in-action/ [...]</description>
		<content:encoded><![CDATA[<p>[...] <a href="http://venturebeat.com/2008/11/18/the-genomic-frontier-personalized-medicine-in-action/" rel="nofollow">http://venturebeat.com/2008/11/18/the-genomic-frontier-personalized-medicine-in-action/</a> [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
